100 Jahre Vitamin-E-Forschung: Status, Ausblick und zukünftige Entwicklungen

Neue Ansätze zur Rolle von Vitamin E in verschiedenen Bereichen der menschlichen Gesundheit werden in verschiedenen Arbeitsgruppen untersucht und versprechen neue Anwendungen in der gesundheitlichen Unterstützung von Risikogruppen. Nach 100 Jahren Forschung zu und über Vitamin E eröffnen neue Technologien und Studien auch für die Zukunft vielversprechende zusätzliche Funktionen und Anwendungsmöglichkeiten in der Risikoprävention.

Publication History

Article published online:
07 June 2022

• Literatur

• 1 Horwitt MK. Vitamin E and lipid metabolism in man. Am J Clin Nutr 1960; 8: 451-461
• 2 Peter S, Friedel A, Roos FF. et al. A systematic review of global alpha-tocopherol status as assessed by nutritional intake levels and blood serum concentrations. Int J Vitam Nutr Res 2015; 85: 261-281
• 3 Traber MG. Vitamin E too much or not enough?. Am J Clin Nutr 2001; 73: 997-998
• 4 Kohlschütter AF, Finck B, Nickel M. et al. First recognized patient with genetic vitamin E deficiency stable after 36 years of controlled supplement therapy. Neurodegener Dis 2020; 20: 35-38
• 5 Sieber CC. „Inflammaging“ – Altern als Folge von Entzündungsvorgängen. Dtsch Med Wochenschr 2016; 141: 750
• 6 Meydani SN, Lewis ED, Wu D. Perspective: Should vitamin E recommendations for older adults be increased?. Adv Nutr 2018; 9: 533-543
• 7 Max Rubner-Institut. Ergebnisbericht Teil 2 Nationale Verzehrsstudie II 2008. Im Internet: https://www.mri.bund.de/fileadmin/MRI/Institute/EV/NVSII_Abschlussbericht_Teil_2.pdf Stand 06.04.2022
• 8 Peter S, Moser U, Pilz S. et al. The challenge of setting appropriate intake recommendations for vitamin E consideration on status. Int J Vitam Nutr Res 2013; 83: 1-8
• 9 Lebold KM, Ang A, Traber MG, Arab L. Urinary alpha-carboxyethyl hydroxychroman can be used as a predictor of alpha-tocopherol adequacy, as demonstrated in the Energetics Study. Am J Clin Nutr 2012; 96: 801-809
• 10 Stampfer MJ, Hennekens CH, Manson JE. et al. Vitamin E consumption and the risk of coronory disease in women. N Engl J Med 1993; 328: 1444-1449
• 11 Knekt P, Reunanen A, Jävinen R. et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180-1189
• 12 Mayne S. The effect of vitamin E and beta carotene on the incidence of lung cancer. N Engl J Med 1994; 330: 1029-1035
• 13 Gridley G, McLaughlin JK, Block G. et al. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am J Epidemiol 1992; 135: 1083-1092
• 14 Lee I, Cook NR, Gaziano MJ. et al. Vitamin E in the primary prevention of cardiovascular disease and cancer. JAMA 2005; 294: 56-65
• 15 Miller ER, Pastor-Barriuso R, Dalal D. et al. Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Annals Intern Med 2005; 142: 37-46
• 16 McBurney MI, Yu EA, Ciappio ED. et al. Suboptimal serum alpha-tocopherol concentrations observed among younger adults and those depending exclusively upon food sources, NHANES 2003-2006(1-3). PLoS One 2015; 10: e0135510
• 17 West KP, Cole RN, Shrestha S. et al. A plasma alpha-tocopherome can be identified from proteins associated with vitamin E status in school-aged children of Nepal. J Nutr 2015; 145: 2646-2656
• 18 Gupta A, Kumar R, Ganguly R. et al. Antioxidant, anti-inflammatory, and hepatoprotective activities of Terminalia bellirica and its bioactive component ellagic acid against diclofenac induced oxidative stress and hepatotoxicity. Toxicol Rep 2020; 8: 44-52
• 19 Howard AC, McNeil AK, McNeil PL. Promotion of plasma membrane repair by vitamin E. Nat Commun 2011; 2: 597
• 20 Blum S, Vardi M, Levy NS. et al. The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Atherosclerosis 2010; 211: 25-27
• 21 Choi J, Leonard SW, Kasper K. et al. Novel function of vitamin E in regulation of zebrafish (Danio rerio) brain lysophospholipids discovered using lipidomics. J Lipid Res 2015; 56: 1182-1190
• 22 Dysken MW, Sano M, Asthana S. et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014; 311: 33-44
• 23 Podszun MC, Alawad AS, Lingala S. et al. Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biol 2020; 37: 101710
• 24 Wallert MM, Rennert SK. et al. Long-chain metabolites of α-tocopherol occur in human serum and inhibit macrophage foam cell formation in vitro. Free Radic Biol Med 2014; 68: 43-51
• 25 Ciffolilli SW, Bartolini M, Krauth D. et al. Human serum determination and in vitro anti-inflammatory activity of the vitamin E metabolite α-(13’-hydroxy)-6-hydroxychroman. Free Radic Biol Med 2015; 89: 952-962
• 26 Galli F, Azzi A, Birringer M. et al. Vitamin E: Emerging aspects and new directions. Free Radic Biol Med 2017; 102: 16-36
• 27 Meydani SN, Leka LS, Fine BC. et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004; 292: 828-836
• 28 Wallert M, Bormel L, Lorkowski S. Inflammatory diseases and vitamin E – What do we know and where do we go?. Mol Nutr Food Res 2021; 65: e2000097
• 29 Chew EY. Lutein+zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 2013; 309: 2005-2015
• 30 Traber MG. Vitamin E: necessary nutrient for neural development and cognitive function. Proc Nutr Soc 2021; 80: 319-326